U.S. FDA says Evusheld may not protect against Omicron subvariant XBB.1.5

Australia News News

U.S. FDA says Evusheld may not protect against Omicron subvariant XBB.1.5
Australia Latest News,Australia Headlines
  • 📰 Reuters
  • ⏱ Reading Time:
  • 32 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 16%
  • Publisher: 97%

The U.S. Food and Drug Administration said on Friday it does not expect AstraZeneca's COVID-19 antibody cocktail Evusheld to provide protection against the Omicron subvariant XBB.1.5.

Jan 6 - The U.S. Food and Drug Administration said on Friday it does not expect AstraZeneca'sThe subvariant has been causing concern among scientists after its rapid spread in the United States in December.

While the agency is awaiting additional data to verify how Evusheld works against XBB.1.5, it said it does not expect the drug to neutralize the subvariant due to similarities with other Omicron subvariants against which Evusheld does not work.and is an offshoot of XBB, first detected in October, which is itself a recombinant of two other Omicron sub-variants.

The agency said it was closely monitoring the emergence of the XBB.1.5 subvariant, which accounted forin the United States to prevent COVID-19 infections in individuals with weak immune systems or a history of severe side effects from coronavirus vaccines.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

Reuters /  🏆 2. in US

Australia Latest News, Australia Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Are the New XBB COVID Variants Increasing in Colorado?Are the New XBB COVID Variants Increasing in Colorado?According to CDPHE the new variants are likely to become the dominant ones in the state... Covid_19 xbbvariant
Read more »

AstraZeneca's COVID drug Evusheld unlikely to neutralize newest variant, FDA saysAstraZeneca's COVID drug Evusheld unlikely to neutralize newest variant, FDA saysThe Food and Drug Administration late Friday said that AstraZeneca Plc's undefined COVID-19 drug Evusheld may not provide protection against developing the...
Read more »

What we know about Omicron subvariant XBB.1.5 spreading across the USWhat we know about Omicron subvariant XBB.1.5 spreading across the USBy the end of December, XBB.1.5 was responsible for 40% of cases in the U.S., according to data from the CDC.
Read more »

New COVID omicron subvariant XBB.1.5 is ‘spreading like wildfire’ in US: Health experts reveal whyNew COVID omicron subvariant XBB.1.5 is ‘spreading like wildfire’ in US: Health experts reveal whyA new COVID-19 subvariant, XBB.1.5, is picking up speed nationwide. Dr. Marc Siegel and University of Arizona medical professor Dr. Shad Marvasti reveal what's worrisome about the contagious strain.
Read more »

New Omicron subvariant XBB.1.5 ‘most transmissible’ COVID yet, WHO warnsNew Omicron subvariant XBB.1.5 ‘most transmissible’ COVID yet, WHO warnsThe latest Omicron subvariant, XBB1.5, is the most transmissible strain of COVID yet — but does not seem to make people sicker, the World Health Organization said.
Read more »

Is the Omicron Subvariant XBB.1.5 Really More Contagious Than Other Variants?Is the Omicron Subvariant XBB.1.5 Really More Contagious Than Other Variants?It’s rapidly taking over COVID-19 cases in the U.S.
Read more »



Render Time: 2025-02-28 02:07:13